2026 Oncology Conference: THMA Oncology Forum
September 16-18, 2026
Boston, MA
The THMA Oncology Forum is an invitation-only oncology conference held in person twice a year, connecting commercial leaders from pharma and life sciences with senior oncology service line executives from the nation’s leading health systems.
The Forum runs as a closed-door, peer-level meeting. A strict 1:1 health system-to-industry ratio keeps the room balanced, and the agenda is built from the decisions oncology leaders are making right now.
At the Forum, you engage directly with the decision-makers who shape:
Clinical pathway inclusion, treatment sequencing, and real-world prescribing behavior
Formulary positioning, utilization management, and access execution workflows
Operational rollout and implementation across health system networks and sites of care
Upcoming Event Dates and Locations
The Oncology Forum is hosted twice a year in thoughtfully selected locations across the country. Each event is timed to align with evolving industry priorities, providing a fresh opportunity to reconnect with peers, gain new insights, and advance your healthcare financial strategy.
What the Oncology Forum Covers
The agenda is rebuilt for every Forum around the decisions oncology leaders are facing that year, so no two are alike. Five themes recur.
Service Line Strategy and Investment. Where cancer fits into enterprise priorities, how capital and talent get allocated, where investment has the most impact, and what integrated, research-infused cancer care has to look like to compete over the next decade. Sessions take participants inside how systems like Mass General Brigham and Duke Health make those calls.
Care Delivery and Site-of-Care Economics. Infusion strategy, moving services off the hospital campus, operating a suite where demand and workforce no longer align, and responding to payer and policy pressure on the drug margin supporting the program.
Emerging Clinical and Population Challenges. The shifts reshaping who oncology programs serve and how, including early-onset cancers in younger patients, cardio-oncology for a growing population of patients living beyond cancer treatment, the specialty lines programs have to navigate to serve them, and survivorship and supportive care services that expand patient access and create value for patients, healthcare providers, and the health system.
Policy, Coverage, and Reimbursement. What is moving in Washington on drug pricing, coverage design, and payment reform, how those changes land on pathway governance, prior authorization, and site-of-care decisions, and how oncology leaders navigate them without overcommitting to rules that may not hold.
Innovation, Precision Medicine, and Clinical Trial Access. How health systems evaluate products and partnerships, fund precision medicine at scale, and work through the fragmented enrollment and limited patient awareness that keep cancer patients out of trials that could change their treatment.
Sessions are led by oncology executives, researchers, and clinical leaders from health systems such as Mass General Brigham, Duke Health, Penn Medicine, Carilion Clinic, ChristianaCare, and Corewell Health. The full agenda for the next Forum is available on request.
The Oncology Forum Experience
The Oncology Forum is an in-person event from start to finish, and the agenda is designed around what gets said in the room and in the hours around it. Across three days in Boston, participants discuss:
How pathway governance and cost pressures are reshaping prescribing decisions
Where evolving access requirements are creating friction or opportunity
What health systems need to adopt and sustain new cancer treatments in ways that hold up in practice and improve patient care and patient outcomes
These insights directly inform commercialization strategy, enabling faster traction, stronger pull-through, and more durable market impact.
Structured sessions sit alongside shared meals and member activities that make in-person collaboration easy. In Boston, that includes a private, behind-the-scenes tour of Fenway Park and a Taste of Boston reception and dinner. Meeting in person is what lets a first conversation turn into a working relationship, and the people attendees connect with over three days are the ones they call during the year that follows.
Health System Forum Members
What Sets Oncology Forum Apart
The Right People, in the Right Room: All participants are carefully vetted and hand-selected to ensure meaningful contribution and strategic relevance. Attendees include senior Oncology Service Line Executives from leading health systems such as Mayo Clinic, Yale New Haven Health, Baptist MD Anderson Cancer Center, Baptist Health, and other nationally recognized organizations, alongside select industry leaders.
Purposeful Industry Participation: Industry Members are thoughtfully curated to support high-value dialogue and shared learning, creating an environment focused on insight generation rather than transactional networking.
Provider-Validated Intelligence: Gain unfiltered perspective on how oncology decisions are made, where implementation challenges emerge, and which tools and partnerships drive sustainable adoption across health systems.
Relationships Built on Trust: The Forum is designed to foster long-term, credible relationships with oncology leaders through both structured engagement and informal connection, enabling collaboration that continues well beyond the event itself.
What Participants Are Saying
The Oncology Forum creates a purpose-built space for executive-level engagement. Every session, social setting, and touchpoint is curated to foster meaningful, candid dialogue between fellow Oncology Service Line Executives and select industry innovators, most commonly CEOs, Chief Growth Officers, and strategic product leaders.
Extending Value Beyond the Oncology Conference
Members gain access to a year-round ecosystem of insight and engagement through THMA’s Executive Insights Hub. The platform brings together the trends and challenges unique to strategic planning, alongside trending CXO priorities from large health systems across the country. Our other year-round resources include:
Quarterly Trend Reports: Digestible insights and follow-ups from live briefings and proprietary research.
Executive Edge: A Sunday evening digest with quick-read summaries of industry-impacting events.
Post-Forum Debriefs: Key takeaways and insights from our Forums - useful even for teammates who did not attend.
Healthcare Bootcamp: A library of short videos and modules to onboard new team members or sharpen your team’s healthcare knowledge, with practical tools your team can apply between events to build shared knowledge across the organization. Together, these tools give members the education, market information, and working knowledge to act on what they learn at the Forum long after the conference ends, and to track progress against the priorities they set there.
Industry Forum Members
Our Convening Experiences
Frequently Asked Questions About the Oncology Forum
What is the THMA Oncology Forum?
The THMA Oncology Forum is an invitation-only oncology conference that convenes senior oncology service line executives from leading U.S. health systems with commercial leaders from pharma, life sciences, and other industry organizations. The Forum is hosted in person twice a year and runs as a closed-door meeting rather than an open-registration event.
Who attends the Oncology Forum?
Attendees are senior Oncology Service Line Executives from health systems including Mayo Clinic, Yale New Haven Health, Baptist MD Anderson Cancer Center, and Baptist Health, alongside a curated group of industry leaders, most commonly CEOs, Chief Growth Officers, and strategic product leaders. Every participant is vetted, and the Forum holds a 1:1 health system-to-industry ratio, so no one spends the meeting outnumbered.
How is the Oncology Forum different from other oncology conferences?
Most oncology conferences are organized around large-scale scientific programming and open registration. The Oncology Forum is capped, vetted, and closed-door. Participants spend three days in person, in structured peer dialogue and informal connection with a balanced room of health system and industry decision-makers, which is what makes the insight provider-validated rather than self-reported.
Is the Oncology Forum held in person or virtually?
The Oncology Forum is held in person. Sessions, meals, and member activities all take place on site. Nothing is streamed or offered virtually, because the candor that makes the meeting valuable depends on everyone being in the same room in person.
What topics does the Oncology Forum cover?
Sessions are built around the decisions oncology leaders face in the current year. The agenda covers infusion care strategy, cancer program investment and governance, early-onset colorectal cancer, cardio-oncology, survivorship and supportive care, clinical trial access, and the federal policy shaping cancer care delivery.
Can industry organizations attend the Oncology Forum?
Yes. Industry participation is curated rather than open. Industry organizations engage through THMA’s Executive Convening membership, and we are happy to share information about how participation works.
How do I attend the Oncology Forum?
Attendance is by invitation. Health system executives and industry organizations can request information using the form on this page, and a member of our team will follow up with the date and details of the next Forum.
About The Health Management Academy
Since 1998, The Health Management Academy has cultivated the premier membership-based community of healthcare’s most influential CXOs from top U.S. health systems, as well as decision makers from innovative industry companies.
We cultivate exceptional peer groups, providing original market insights, world-class leadership development programs, and novel member alliances to more than 2,000 health system senior executives and 200 industry organizations.
2,500+
Health System Executives
600+
Health System C-Suite Members
300+
Industry Members
28+
Years of Convening
